Welcome to LookChem.com Sign In|Join Free

CAS

  • or

7182-09-4

Post Buying Request

7182-09-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7182-09-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7182-09-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,1,8 and 2 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 7182-09:
(6*7)+(5*1)+(4*8)+(3*2)+(2*0)+(1*9)=94
94 % 10 = 4
So 7182-09-4 is a valid CAS Registry Number.
InChI:InChI=1/C8H15N/c1-2-6-9-7-4-3-5-8-9/h2,6H,3-5,7-8H2,1H3/b6-2+

7182-09-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[(E)-prop-1-enyl]piperidine

1.2 Other means of identification

Product number -
Other names N-(1-propenyl)piperidine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:7182-09-4 SDS

7182-09-4Relevant articles and documents

CARBAZOLE-CONTAINING AMIDES, CARBAMATES, AND UREAS AS CRYPTOCHROME MODULATORS

-

Paragraph 0394, (2015/10/28)

The subject matter herein is directed to carbazole-containing amide, carbamate, and urea derivatives and pharmaceutically acceptable salts or hydrates thereof of structural formula I wherein the variable R1, R2, R3, R4, R5, R6, R7, A, D, E, G, J, L, M, Q, a, and b are accordingly described. Also provided are pharmaceutical compositions containing the compounds of formula I to treat a Cry-mediated disease or disorder, such as diabetes, complications associated with diabetes, Cushing's syndrome, NASH, NAFLD, asthma, and COPD.

The total synthesis of (-)-aurafuron A

Hartmann, Olaf,Kalesse, Markus

supporting information; experimental part, p. 3064 - 3067 (2012/09/08)

The first total synthesis of (-)-aurafuron A is presented. It features a Suzuki cross-coupling reaction and a high yielding anionic aldol addition as central carbon skeleton building reactions. The synthesis confirms the proposed structure including its configuration and allows for detailed SAR studies.

Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors

Chen, Yuan,Chen, Shaopeng,Lu, Xin,Cheng, Hao,Ou, Yingyong,Cheng, Huimin,Zhou, Guo-Chun

scheme or table, p. 1851 - 1854 (2009/11/30)

A series of benzofuran derivatives were synthesized and evaluated against HUVEC proliferation. Among these compounds, compound 32 exhibited good inhibitory activity and remarkable selectivity to HUVEC. Our current data suggested that array order of methyl, acrylate and carboxylate groups in benzofuran scaffold is the basic requirement for inhibitory activity against HUVEC proliferation. These results demonstrated that benzofuran scaffold represents a promising structural core to discover a new class of active and selective angiogenesis inhibitors.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 7182-09-4